Article thumbnail

Meta-Analysis of TNF 308 G/A Polymorphism and Type 2 Diabetes Mellitus

By Ren-Nan Feng, Chen Zhao, Chang-Hao Sun and Ying Li
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2006). [Association between tumor necrosis factor-alpha promoter polymorphisms and type 2 diabetes and obesity in Chilean elderly women].
  2. (2003). 2308 Nco I polymorphism of tumour necrosis factor alpha in overweight Caucasians.
  3. (2003). A combination of human leukocyte antigen DQB1*02 and the tumor necrosis factor alpha promoter G308A polymorphism predisposes to an insulin-deficient phenotype in patients with type 2 diabetes.
  4. (2003). A polymorphism in the promoter of the tumor necrosis factor-alpha gene (2308) is associated with coronary heart disease in type 2 diabetic patients.
  5. (1993). Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.
  6. (2008). Association between LTA, TNF and AGER polymorphisms and late diabetic complications.
  7. (2002). Association of the TNF-alpha 2308 G/A promoter polymorphism with insulin resistance in obesity.
  8. (2002). Association of the tumour necrosis factor alpha 2308G/A polymorphism with the risk of diabetes in an elderly population-based cohort.
  9. (1998). Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse.
  10. (2009). diabetes: a meta-analysis. Acta Diabetol.
  11. (1997). Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.
  12. (2006). Epidemic obesity and type 2 diabetes in Asia.
  13. (2000). Excessive fat accumulation is associated with the TNF alpha-308 G/A promoter polymorphism in women but not in men.
  14. (2000). Gene polymorphisms in the TNF locus and the risk of myocardial infarction.
  15. (1995). Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM).
  16. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care
  17. (1992). Haplospecific polymorphism between HLA B and tumor necrosis factor.
  18. (2008). Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes.
  19. (2006). Inflammation and metabolic disorders.
  20. (2010). Large-scale association analysis of TNF/LTA gene region polymorphisms in type 2 diabetes.
  21. (2005). Largescale studies of the association between variation at the TNF/LTA locus and susceptibility to type 2 diabetes.
  22. (2005). Meta-analysis on the G-308A tumor necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome.
  23. (1993). No independent association between a tumor necrosis factor-alpha promotor region polymorphism and insulin-dependent diabetes mellitus.
  24. (1998). Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity.
  25. (2002). Relationship of the tumor necrosis factor-alpha 2308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus.
  26. (2010). Study of TNFalpha 2308G/A and IL6 2174G/C polymorphisms in type 2 diabetes and obesity risk in the Tunisian population.
  27. (2009). TNF 308 G/A polymorphism and type 1 diabetes: a meta-analysis.
  28. (2003). TNF-alpha polymorphisms and type 2 diabetes mellitus in Taiwanese patients.
  29. (2004). TNF-alpha, TGF-beta1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes mellitus.
  30. (2003). TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes.
  31. (2007). TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ.
  32. (2000). Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome.
  33. (2000). Tumor necrosis factor alpha gene G-308A polymorphism, insulin resistance, and fasting plasma glucose in young, older, and diabetic Japanese men.
  34. (2001). Tumor necrosis factor-alpha–308 G/A polymorphism in obese Caucasians.
  35. (1998). Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans.
  36. (2003). Tumour necrosis factoralpha promoter gene polymorphism at 2308 (genotype AA) in Chinese subjects with Type 2 diabetes.